Senior insider sale
President and CEO at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$438.5K
243.98K shares
What this filing means
CHANG DAVID D plans to sell 243.98K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $438.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001950047-26-000843
DirectorOfficer· President and CEO
Since Oct 2018
243.98K
Shares to sell
$438.5K
Approx. market value
243.98K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
1/31/2026
243.98KTotal acquired243.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted stock vesting under a registered plan Compensation | 243.98K | — |
| Total | 243.98K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
243.98K
Market value
$438.5K
2/2/2026
Total
Units
243.98K
Value
$438.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2026 | 243.98K | $438.5K | NASDAQ | Planned |
| Total | 243.98K | $438.5K | ||